
sRAGE linked to risk of incident diabetic nephropathy
(HealthDay)—Serum levels of soluble receptor for advanced glycation end products (sRAGE) are associated with the risk of developing incident diabetic nephropathy (DN) in individuals with type 1 diabetes, according to a ...
Jun 22, 2017
0
0